Efficacy of XELOX plus Bevacizumab in Brain Metastasis from Rectal Cancer

Brain metastasis (BM) is rare in colorectal cancer (CRC) patients. Although BM from CRC is a late-stage phenomenon with an extremely poor prognosis, some subsets of patients would benefit from a multidisciplinary management strategy. The prognosis of patients with BM from CRC was associated with the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Yoichiro, Hoshino, Seiichiro, Aisu, Naoya, Naito, Masayasu, Tanimura, Syu, Sasaki, Takamitsu, Takeno, Shinsuke, Yamashita, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2014
Materias:
Published online: February, 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975757/
https://www.ncbi.nlm.nih.gov/pubmed/24707258
http://dx.doi.org/10.1159/000360132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975757/
https://www.ncbi.nlm.nih.gov/pubmed/24707258
http://dx.doi.org/10.1159/000360132

Ejemplares similares